ND-630
ND-630 is potent, and reversible acetyl-CoA carboxylase (ACC) inhibitor; inhibits human ACC1 and ACC2 with IC₅₀ values of 2.1 and 6.1 nM, respectively. When administered chronically to Zucker diabetic fatty rats, ND-630 reduces hepatic steatosis, improves glucose-stimulated insulin secretion, and reduces hemoglobin A1c (0.9% reduction).
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0074108 1.0 µg DNA
ALG11 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details MF-0052576-01 10 mg
2'-Deoxy-2'- (N-trifluoroacetyl) amino-5'-O-DMTr-uridine 3'-CED phosphoramidite
Sign In for Pricing
View Details MF-0052576-02 100 mg
2'-Deoxy-2'- (N-trifluoroacetyl) amino-5'-O-DMTr-uridine 3'-CED phosphoramidite
Sign In for Pricing
View Details 
MF-0052576-03 25 mg
2'-Deoxy-2'- (N-trifluoroacetyl) amino-5'-O-DMTr-uridine 3'-CED phosphoramidite
Sign In for Pricing
View Details